Identification of Senescent Cells in the Bone Microenvironment

Journal of Bone and Mineral Research

Volumn 31, Issue 11, 2016, Pages 1920-1929

  Farr, Joshua N ^a   Fraser, Daniel G ^a   Wang, Haitao ^b   Jaehn, Katharina ^c   Ogrodnik, Mikolaj B ^a   Weivoda, Megan M ^a   Drake, Matthew T ^a   Tchkonia, Tamara ^a   LeBrasseur, Nathan K ^a   Kirkland, James L ^a   Bonewald, Lynda F ^c   Pignolo, Robert J ^b   Monroe, David G ^a   Khosla, Sundeep ^a  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

AGING; ANIMAL MODELS; CELL TISSUE SIGNALING; OSTEOCYTES

Indexed keywords

CELL PROTEIN; SATELLITE DNA; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; FEMALE; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; T LYMPHOCYTE; TELOMERE SHORTENING; UPREGULATION; ANIMAL; C57BL MOUSE; CELL AGING; CELL CULTURE; CELL LINEAGE; CYTOLOGY; METABOLISM; PHENOTYPE; TUMOR MICROENVIRONMENT;

ANIMALS; BIOMARKERS; BONE AND BONES; CELL LINEAGE; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CELLULAR SENESCENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, SATELLITE; FEMALE; MALE; MICE, INBRED C57BL; MYELOID CELLS; OSTEOBLASTS; OSTEOCYTES; PHENOTYPE;

EID: 84997216961     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2892     Document Type: Article

References (49)

1. Goldman DP, Cutler D, Rowe JW, et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood). 2013; 32(10):1698–1705.
2. Tchkonia T, Zhu Y, Van Deuersen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013; 123:966–72.
3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439–46.
4. Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015; 21(12):1424–35.
5. Swanson EC, Manning B, Zhang H, Lawrence JB. Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence. J Cell Biol. 2013; 203(6):929–42.
6. von Zglinicki T, Saretzki G, Ladhoff J, d'Adda di Fagagna F, Jackson SP. Human cell senescence as a DNA damage response. Mech Ageing Dev. 2005; 126(1):111–17.
7. Ziegler DV, Wiley CD, Velarde MC. Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging. Aging Cell. 2015; 14(1):1–7.
8. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 1995; 55(11):2284–92.
9. Coppé JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6(12):2853–68.
10. Acosta JC, Banito A, Wuestefeld T, et al. A complex secretory program orchestrated by the inflammasomes controls paracrine senescence. Nat Cell Biol. 2013; 15(8):978–90.
11. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5:99–118.
12. Nelson G, Wordsworth J, Wang C, et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell. 2012; 11(2):345–49.
13. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science. 2006; 311:1257.
14. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delay aging-associated disorders. Nature. 2011; 479(7372):232–36.
15. Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016 Feb 11; 530(7589):184–9. doi: 10.1038/nature16932.
16. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015; 14(4):644–58.
17. Kassem M, Marie PJ. Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell. 2011; 10(2):191–97.
18. Marie PJ. Bone cell senescence: mechanisms and perspectives. J Bone Miner Res. 2014; 29(6):1311–21.
19. Chen Q, Liu K, Robinson AR, et al. DNA damage drives accelerated bone aging via an NF-kB-dependent mechanism. J Bone Miner Res. 2013; 28:1214–28.
20. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004; 114(9):1299–1307.
21. Burd CE, Sorrentino JA, Clark KS, et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a) luciferase model. Cell. 2013; 152(1-2):340–51.
22. Waaijer ME, Parish WE, Strongitharm BH, et al. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012; 11(4):722–25.
23. Beauséjour CM, Krtolica A, Galimi F, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 2003; 22(16):4212–22.
24. Baker DJ, Weaver RL, van Deursen JM. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep. 2013; 3(4):1164–74.
25. Itoh S, Aubin JE. A novel purification method for multipotential skeletal stem cells. J Cell Biochem. 2009; 108:368–77.
26. Syed FA, Modder UI, Roforth M, et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res. 2010; 25(11):2438–46.
27. Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014; 15:154–68.
28. Fujita K, Roforth MM, Atkinson EJ, et al. Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporos Int. 2014; 25:887–95.
29. Qing H, Ardeshirpour L, Pajevic PD, et al. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res. 2012; 27(5):1018–29.
30. Farr JN, Roforth MM, Fujita K, et al. Effects of age and estrogen on skeletal gene expression in humans as assessed by RNA sequencing. PLoS One. 2015; 10:e0138347.
31. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide experssion profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545–50.
32. Efron B, Tibshirani R. On testing the significance of sets of genes. Ann Appl Statist. 2007; 1(1):107–29.
33. Paic F, Igwe JC, Nori R, et al. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone. 2009; 45(4):682–92.
34. Nioi P, Taylor S, Hu R, et al. Transcriptional profiling of laser capture microdissected subpopulations of the osteoblast lineage provides insight into the early response to sclerostin antibody in rats. J Bone Miner Res. 2015; 30(8):1457–67.
35. Kang C, Xu Q, Martin TD, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015; 349(6255):aaa5612.
36. Garcia-Prat L, Martinez-Vicente M, Perdiguero E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016; 529(7584):37–42.
37. Komatsu M, Waguri S, Ueno T, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol. 2005; 169(3):425–34.
38. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19(21):5720–28.
39. Stern AR, Stern MM, Van Dyke ME, Jahn K, Prideaux M, Bonewald LF. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques. 2012; 52(6):361–73.
40. Kenyon J, Gerson SL. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2007; 35(22):7557–65.
41. Jurk D, Wang C, Miwa S, et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell. 2012; 11(6):996–1004.
42. Jurk D, Wilson C, Passos JF, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. 2014; 2:4172.
43. Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009; 15(9):1082–87.
44. Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell.. and more. Endocr Rev. 2013; 34:658–90.
45. Salminen A, Kauppinen A, Kaarniranta K. Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal. 2012; 24(4):835–45.
46. Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17(10):1231–34.
47. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’ Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17(10):1235–41.
48. Lu Y, Xie Y, Zhang S, Dusevich V, Bonewald LF, Feng JQ. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res. 2007; 86(4):320–25.
49. Onal M, Piemontese M, Xiong J, et al. Suppression of autophagy in osteocytes mimics skeletal aging. J Biol Chem. 2013; 288(24):17432–40.